¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÇ÷°ü¿Ü°úÇÐȸ The 13th Seoul Bi-Vascular Symposium : 2023-03-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÇ÷°ü¿Ü°úÇÐȸ The 13th Seoul Bi-Vascular Symposium : 2023-03-25
±³À°ÀÏÀÚ : 2023-03-25
±³À°Àå¼Ò : The K È£ÅÚ ±Ý°­È¦

±³À°ÁÖÁ¦ : The 13th Seoul Bi-Vascular Symposium

ÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Bi-vascular

´ã´çÀÚ : ÇÔ»óÇù
¿¬¶ôó : 02-3144-2227

À̸ÞÀÏ : bivascular@naver.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 58ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í Àü¹®ÀÇ/ÀϹÝÀÇ/°øº¸ÀÇ/±ºÀÇ°ü: »çÀü:20,000¿ø, ÇöÀå:50,000¿øÀüÀÓÀÇ/Àü°øÀÇ/±âŸ: »çÀü: ¹«·á, ÇöÀå: 20,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:00~09:15 Recorded live case 1: FEVAR William J Yoon(Case Western Reserve Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:15~09:30 Recorded live case 2: Treatment for chronic type B aortic dissection ÀÓ¼ºÈ£(Rush Univ Medical Center USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:30~09:36 Has the NICE guideline for AAA changed the AAA practice pattern? ¾ç½Å¼®(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:36~09:42 What will be the last one standing fEVAR, chEVAR, ESAR, or OSAR? William J Yoon(Case Western Reserve Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:42~09:48 Current EVARs are performed on AAAs smaller than the guideline recommends, Are ruler takers just blind? ÀüÈ︸(°í·ÁÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:48~09:54 Small AAA are not all the same, The gray zone of guideline Daniel K. Han(Mount Sinai Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 09:54~10:00 The optimal treatment of aortic and graft Infections and alternative options (when is percutaneous drainage acceptable) Çã½Â(°æºÏÀÇ´ë)

Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 10:00~10:30 Discusion ()

ÈÞ½Ä 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 10:30~10:50 Coffee Break ()

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 10:50~11:05 Recorded live case 3: Complex aortoiliac obstructions endo Jayer Chung(Baylor Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:05~11:20 Recorded live case 4: Pedal bypass ¾ÈÇüÁØ(°æÈñÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:20~11:26 Technical tips for successful EVT in AIOD Á¶ÁøÇö(°æÈñÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:26~11:32 Chronic flush juxtarenal aortic occlusion do need open bypass and technical tips Á¶¿ëÇÊ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:32~11:38 Severely calcified CTO in SFA: What to do? Is atherectomy and DCB the best combination? Cheong Jun Lee(Northshore Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:38~11:44 How to change practice after BEST-CLI report? ÀÌŽÂ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:44~11:50 Clinical scenarios when open bypass is preferred than endo ÇÑ¿µÁø(¿ï»êÀÇ´ë)

Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 11:50~12:20 Discussion ()

½Ä»ç 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 12:20~13:30 lunch ()

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 13:30~13:37 Problems after EVAR can be treated with endovascular therapy ÀÌ»ó¼ö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 13:37~13:44 Early open conversion is more cost-effective than repeated interventions ÀÓ¼ºÈ£(Rush Univ Medical Center USA)

Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 13:44~14:04 Discussion ()

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 14:04~14:11 Regularly checking the VA by ultrasound is not necessary ¹Ú»óÁØ(¿ï»ê´ëº´¿ø)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 14:11~14:18 DUS as a screening tool for detecting stenosis and to perform preemptive interventions can prevent the loss of the AV access ±è´ëȯ(³ªÀº±æ¿Ü°ú)

Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 14:18~14:38 Discussion ()

ÈÞ½Ä 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 14:38~14:55 Coffee Break ()

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 14:55~15:01 How to be misled by RCTs And Meta-Analysis Flawed and Biased ±è¼­¹Î(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 15:01~15:07 How can AI incorporate in Vascular field, and who will drive? ¾çµ¿Çö(¿ï»êÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 15:07~15:13 Rare disease consortium: K-RARE ¹Î½Â±â(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 15:13~15:19 How to make an optimal graft xenograft, peritoneum and new materials ÇѾƶ÷(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 15:19~15:25 The significance of endograft geometry on hemodynamics by using computational fluid dynamic analysis William J Yoon(Case Western Reserve Univ. USA)

Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 15:25~15:50 Discussion ()

ÈÞ½Ä 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 15:50~16:00 Coffee Break ()

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:00~16:06 Endovascular solution of PE When, why how À̸í¼ö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:06~16:12 Percutaneous thromboembolectomy Which device to in certain clinical scenarios? Daniel K. Han(Mount Sinai Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:12~16:18 Endolymphatic intervention: How far have you been? Çã¼¼¹ü(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:18~16:24 Practical combination for lowering LDL-C In Vascular Patients: New adjunctive drugs with statin °­Áø¸ð(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:24~16:30 Wisdom of failure with new low profile endograft devices Cheong Jun Lee(Northshore Univ. USA)

±³À°½Ã°£ 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:30~16:36 Hemodialysis access management after kidney transplantation ȲÁ¤±â(°¡Å縯ÀÇ´ë)

Åä·Ð 03-25 ´õKÈ£ÅÚ ±Ý°­È¦ 16:36~16:55 Discussion ()

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ The 13th Seoul Bi-Vascular Symposium : 2023-03-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â ´ëÇѳ»ºÐºñÇÐȸ ºÎ¿ï°æÁöȸ ´ç´¢º´±³À°ÀÚ ¿¬¼ö°­Á ¹× ¼¼¹Ì³ª : 2023-03-25
´ÙÀ½±Û 2023 ¿Ü°ú°è ÀÔ¿øÀü´ãÀü¹®ÀÇ ¿¬±¸È¸ Ãá°è ½ÉÆ÷Áö¾ö : 2023-03-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20998 °æ±â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °æÀÎÁöȸ Á¦7ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-23 0 1 18:41:57
20997 ¼­¿ï Á¦18ȸ ´ëÇѺñ°úÇÐȸ ½ÉÆ÷Áö¾ö : 2024-06-23 0 1 18:40:36
20996 ÀÎõ ÀÎÇÏ´ëÇб³º´¿ø Á¦6ȸ ÀÎÇÏÇǺνÉÆ÷Áö¾ö : 2024-06-22 0 1 18:39:09
20995 ¼­¿ï Á¦23ȸ Çѱ¹Á¤¸Æ°æÀ念¾çÇÐȸ Çмú´ëȸ ¹× 2024 ±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-22 0 1 18:35:50
20994 ¼­¿ï 2024³â Á¦2Â÷ ´ëÇѳëÀÎÀÇÇÐ ¼¼ºÎÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 1 18:33:10
20993 ¼­¿ï ´ëÇѼҾÆÀçÈ°¹ß´ÞÀÇÇÐȸ Çмú´ëȸ : 2024-06-22 0 0 18:31:58
20992 °æ±â 2024³â ¾È¾ç½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-22 0 0 18:30:44
20991 ¼­¿ï ´ëÇѼҾƳ»ºÐºñÇÐȸ Á¦18Â÷ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-22 0 0 18:29:18
20990 ¼­¿ï 2024³â Çѱ¹ºÐ¼®½É¸®ÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-22 0 0 18:28:06
20989 ¼­¿ï 2024 ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ ³ú½Å°æÁ¶Àý Moving Symposium : 2024-06-22 0 0 18:26:43
20988 ¼­¿ï 2024 Á¦ 13ȸ ´ëÇѺñ´¢»ý½Ä±âÅëÇÕ±â´ÉÀÇÇבּ¸È¸ Çмú´ëȸ : 2024-06-22 0 14 2024-06-14
20987 Ãæ³² 2024³â ´ëÇÑ°í°üÀýÇÐȸ Áø·áÁöħ ½ÉÆ÷Áö¿ò : 2024-06-22 0 16 2024-06-14
20986 ±¤ÁÖ Á¦24ȸ ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ È£³²Áöȸ Á¤±âÇмú´ëȸ : 2024-06-22 0 17 2024-06-14
20985 °æ±â ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Annual Academy for young oncologists(2ÀÏÂ÷) : 2024-06-22 0 12 2024-06-14
20984 °æºÏ ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦43Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-22 0 10 2024-06-14
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷